Physalin A suppressed tumor growth in a xenograft model using human NSCLC H292 (non-small cell lung cancer cell line), and its effects were related to an increase in caspase-3 activation and inhibition of JAK-STAT3 signaling (Zhu et al., 2016). Here, STAT3 is linked to non-small cell lung carcinoma.